Literature DB >> 15474718

Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.

Julia Macdonald-Fyall1, Dorothy Xing, Michael Corbel, Susan Baillie, Roger Parton, John Coote.   

Abstract

The cell-invasive adenylate cyclase toxin (CyaA) of Bordetella pertussis was shown to be highly antigenic in mice, stimulating serum anti-CyaA IgG antibody responses which were able to neutralise the cytotoxic effect of CyaA on J774.2 macrophage-like cells. The effect of co-administration to mice of the fully functional CyaA toxin or a toxin lacking adenylate cyclase enzymic activity (CyaA*) with other antigens from B. pertussis, namely pertussis toxin (PT) or pertussis toxoid (PTd), filamentous haemagglutinin (FHA) and pertactin (PRN), was investigated. CyaA* enhanced the serum IgG antibody responses to each of these antigens whereas, with CyaA, only anti-PRN antibody titres showed a modest increase. Peritoneal macrophages and spleen cells, collected at 2 weeks post-immunisation, were cultured and tested for nitric oxide (NO) and IFNgamma production, respectively, after stimulation in vitro with heat-killed B. pertussis cells or CyaA proteins. NO and IFNgamma production were higher in cells collected from mice immunised with CyaA or CyaA* in combination with a PT, FHA and PRN antigen mixture than from those taken from mice injected with antigen mixture alone, again with CyaA* acting as a better adjuvant than CyaA. The apparent enhancement of immune responses to the antigen mixture by CyaA* in particular was not paralleled by increased protection of mice against aerosol challenge with B. pertussis, but a statistically significant increase in protection was seen after intranasal challenge with B. parapertussis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474718     DOI: 10.1016/j.vaccine.2004.04.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells.

Authors:  Martina Svedova; Jiri Masin; Radovan Fiser; Ondrej Cerny; Jakub Tomala; Marina Freudenberg; Ludmila Tuckova; Marek Kovar; Gilles Dadaglio; Irena Adkins; Peter Sebo
Journal:  Immunol Cell Biol       Date:  2015-10-06       Impact factor: 5.126

2.  Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.

Authors:  Casandra Hoffman; Joshua Eby; Mary Gray; F Heath Damron; Jeffrey Melvin; Peggy Cotter; Erik Hewlett
Journal:  Mol Microbiol       Date:  2016-11-03       Impact factor: 3.501

3.  Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Authors:  Gordon Y C Cheung; Dorothy Xing; Sandra Prior; Michael J Corbel; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

4.  Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.

Authors:  Dylan T Boehm; Jesse M Hall; Ting Y Wong; Andrea M DiVenere; Emel Sen-Kilic; Justin R Bevere; Shelby D Bradford; Catherine B Blackwood; Cody M Elkins; Katherine A DeRoos; Mary C Gray; C Garret Cooper; Melinda E Varney; Jennifer A Maynard; Erik L Hewlett; Mariette Barbier; F Heath Damron
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

Review 5.  Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.

Authors:  Abdulbaset M Salim; Yan Liang; Paul E Kilgore
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

6.  Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.

Authors:  Hesham F Nawar; Sergio Arce; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

7.  Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity.

Authors:  Sarah Jones; Catpagavalli Asokanathan; Dorota Kmiec; June Irvine; Roland Fleck; Dorothy Xing; Barry Moore; Roger Parton; John Coote
Journal:  Vaccine       Date:  2013-10-10       Impact factor: 3.641

Review 8.  Invasion of Dendritic Cells, Macrophages and Neutrophils by the Bordetella Adenylate Cyclase Toxin: A Subversive Move to Fool Host Immunity.

Authors:  Giorgio Fedele; Ilaria Schiavoni; Irena Adkins; Nela Klimova; Peter Sebo
Journal:  Toxins (Basel)       Date:  2017-09-21       Impact factor: 4.546

9.  The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling.

Authors:  Silvia Rossi Paccani; Marisa Benagiano; Nagaja Capitani; Irene Zornetta; Daniel Ladant; Cesare Montecucco; Mario M D'Elios; Cosima T Baldari
Journal:  PLoS Pathog       Date:  2009-03-06       Impact factor: 6.823

Review 10.  Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy.

Authors:  Alexandre Chenal; Daniel Ladant
Journal:  Toxins (Basel)       Date:  2018-07-20       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.